Preclinical Testing of Thrombolytic Therapy for Acute Ischemic Stroke

[1]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[2]  P. Lapchak,et al.  Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits , 2004, Experimental Neurology.

[3]  R. Medcalf,et al.  Vampire Bat Salivary Plasminogen Activator (Desmoteplase): A Unique Fibrinolytic Enzyme That Does Not Promote Neurodegeneration , 2003, Stroke.

[4]  P. Lapchak.  Development of thrombolytic therapy for stroke: a perspective , 2002, Expert opinion on investigational drugs.

[5]  X. Rabasseda.  Tenecteplase (TNK tissue plasminogen activator): A new fibrinolytic for the acute treatment of myocardial infarction. , 2001, Drugs of today.

[6]  W. Schleuning.  Vampire Bat Plasminogen Activator DSPA-Alpha-1 (Desmoteplase): A Thrombolytic Drug Optimized by Natural Selection , 2001, Pathophysiology of Haemostasis and Thrombosis.

[7]  P. Lyden,et al.  Comparison of TNK With Wild-Type Tissue Plasminogen Activator in a Rabbit Embolic Stroke Model , 2001, Stroke.

[8]  J. Broderick,et al.  Thrombolytic Therapy for Stroke , 2001, Humana Press.

[9]  M. Chopp,et al.  Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat , 2000, Brain Research.

[10]  F. Van de Werf,et al.  The relative rapidity of recanalization induced by recombinant tissue‐type plasminogen activator (r‐tPA) and TNK‐tPA, assessed with enzymatic methods , 2000, Coronary artery disease.

[11]  D. Rijken,et al.  Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro. , 1999, Thrombosis and haemostasis.

[12]  A. Ross.  New plasminogen activators: A clinical review , 1999, Clinical cardiology.

[13]  J. Weitz,et al.  Characterization of the Interactions of Plasminogen and Tissue and Vampire Bat Plasminogen Activators with Fibrinogen, Fibrin, and the Complex of d-Dimer Noncovalently Linked to Fragment E* , 1998, The Journal of Biological Chemistry.

[14]  W. Schleuning,et al.  Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators. , 1998, European journal of biochemistry.

[15]  W. Schleuning,et al.  Structural Features Mediating Fibrin Selectivity of Vampire Bat Plasminogen Activators (*) , 1995, The Journal of Biological Chemistry.

[16]  V. Marder,et al.  Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model. , 1995, Circulation.

[17]  S. Gardell,et al.  Vampire Bat Salivary Plasminogen Activator Evokes Minimal Bleeding Relative to Tissue-Type Plasminogen Activator as Assessed by a Rabbit Cuticle Bleeding Time Model , 1995, Thrombosis and Haemostasis.

[18]  S. Gardell.  The Search for the Ideal Thrombolytic Agent: Maximize the Benefit and Minimize the Risk , 1993, Toxicologic pathology.

[19]  S. Gardell,et al.  Vampire Bat Salivary Plasminogen Activator Promotes Robust Lysis of Plasma Clots in a Plasma Milieu Without Causing Fluid Phase Plasminogen Activation , 1992, Thrombosis and Haemostasis.

[20]  S. Gardell,et al.  Effective Thrombolysis Without Marked Plasminemia After Bolus Intravenous Administration of Vampire Bat Salivary Plasminogen Activator in Rabbits , 1991, Circulation.

[21]  J. Brock,et al.  Differential effect of recombinant tissue plasminogen activator-induced thrombolysis in the central nervous system and systemic arteries. , 1991, Neurosurgery.

[22]  M. Bednar,et al.  Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke. , 1990, Stroke.

[23]  R. Spetzler,et al.  Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected]. , 1990, Stroke.

[24]  P. Lyden,et al.  Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]. , 1990, Stroke.

[25]  R. Fears.  Biochemical pharmacology and therapeutic aspects of thrombolytic agents. , 1990, Pharmacological reviews.

[26]  A. Terashi,et al.  Clinical Effects and Basic Studies of Thrombolytic Therapy on Cerebral Thrombosis , 1990, Seminars in thrombosis and hemostasis.

[27]  O. Al-Mefty,et al.  Efficacy of tissue plasminogen activator in the lysis of thrombosis of the cerebral venous sinus. , 1990, Neurosurgery.

[28]  W. Hacke,et al.  Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. , 1990, Stroke.

[29]  M. A. Davis,et al.  Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model. , 1990, Stroke.

[30]  P. Weinstein,et al.  Protection of the Brain from Ischemia , 1989 .

[31]  D. Vaughan,et al.  Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits. , 1989, The Journal of clinical investigation.

[32]  R. C. Collins,et al.  Selective vulnerability of the brain: new insights into the pathophysiology of stroke. , 1989, Annals of internal medicine.

[33]  G. Press,et al.  Tissue plasminogen activator‐mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits , 1989, Neurology.

[34]  M. Fisher,et al.  The effects of a new tissue plasminogen activator analogue, Fb‐Fb‐CF, on cerebral reperfusion in a rabbit embolic stroke model , 1989, Annals of neurology.

[35]  I. Leusen,et al.  Streptokinase treatment versus calcium overload blockade in experimental thromboembolic stroke. , 1989, Stroke.

[36]  R. Dowman,et al.  Brain tolerance to middle cerebral artery occlusion during hypotension in primates. , 1989, Surgical neurology.

[37]  H. Adams,et al.  Identification and entry of the patient with acute cerebral infarction. , 1988, Annals of emergency medicine.

[38]  E. Braunwald,et al.  Tissue plasminogen activator. , 1988, The New England journal of medicine.

[39]  M. A. Davis,et al.  Selective embolization and clot dissolution with tPA in the internal carotid artery circulation of the rabbit. , 1988, AJNR. American journal of neuroradiology.

[40]  M. Fisher,et al.  The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model , 1988, Annals of neurology.

[41]  P. Lyden,et al.  Tissue Plasminogen Activator: Reduction of Neurologic Damage After Experimental Embolic Stroke , 1988 .

[42]  I. Koc,et al.  [Thrombolysis of cerebral thromboembolism by urokinase in an animal model]. , 1987, Schweizerische medizinische Wochenschrift.

[43]  E. Topol,et al.  Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. , 1987, Journal of neurosurgery.

[44]  J. Seibert,et al.  Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator. , 1987, Journal of neurosurgery.

[45]  P. Penar,et al.  The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia. , 1987, The Yale journal of biology and medicine.

[46]  R. Busto,et al.  Mitigation of evolving cortical infarction in rats by recombinant tissue plasminogen activator following photochemically induced thrombosis , 1987 .

[47]  W. Pulsinelli,et al.  Hemorrhagic complications of thrombolytic therapy in experimental stroke. , 1987, Stroke.

[48]  T. Waltz,et al.  The beneficial effect of intracarotid urokinase on acute stroke in a baboon model. , 1986, Stroke.

[49]  P. Weinstein,et al.  Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats. , 1986, Stroke.

[50]  U. Degirolami,et al.  Tissue plasminogen activator reduces neurological damage after cerebral embolism. , 1985, Science.

[51]  D. Hackney,et al.  Streptokinase clot lysis in acute occlusions of the cranial circulation: study in rabbits. , 1985, AJNR. American journal of neuroradiology.

[52]  M. C. Rogers,et al.  Cerebral vascular diseases. , 1985, Critical care clinics.

[53]  A. Ommaya,et al.  Temporary Occlusion of the Middle Cerebral Artery in the Monkey: Clinical and Pathological Observations , 1970, Stroke.

[54]  Whisnant Jp,et al.  Cerebral infarction and fibrinolytic agents. , 1960 .